TRICARES

TRiCares Announces First U.S. Implantations of Topaz TTVR System in Early Feasibility Study

- TRiCares has successfully implanted its Topaz transcatheter tricuspid heart valve replacement (TTVR) system in the first patients in a U.S. Early Feasibility Study. - The TRICURE EFS (NCT06506942) will evaluate the safety and performance of the Topaz TTVR system in adults with severe tricuspid regurgitation at increased operative risk. - The initial implantations were performed at Piedmont Heart Institute and the Medical University of South Carolina, with both patients recovering well post-procedure. - TRiCares is also progressing with its TRICURE EU Pivotal study in Europe, marking significant steps toward regulatory approvals for the Topaz valve.